Trial site
Gabrail Cancer Center
- 34running trials
- 10closed trials
The trials here
What the 44 trials at this site are about, from their registry records.
- Conditions
- Lung cancer13 trials
- Colorectal cancer7 trials
- Myeloproliferative neoplasms5 trials
- Metastatic breast cancer4 trials
- Acute myeloid leukaemia3 trials
- Endometrial cancer3 trials
- Gastric and oesophageal cancer3 trials
- Liver and biliary tract cancer3 trials
- Multiple myeloma3 trials
- Pancreatic cancer3 trials
- Bladder cancer2 trials
- Head and neck cancer2 trials
- and 13 more
- Phase
- Phase 317 trials
- Phase 210 trials
- Phase 18 trials
- Phase 1/26 trials
- Phase 2/31 trial
- Status
- Recruiting18 trials
- Active, not recruiting16 trials
- Completed5 trials
- Terminated3 trials
- Withdrawn2 trials
- Lead sponsor
- Janssen Research & Development, LLC6 trials
- Cue Biopharma2 trials
- HUYABIO International, LLC.2 trials
- Kartos Therapeutics, Inc.2 trials
- Acrivon Therapeutics1 trial
- and 31 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
Active, not recruiting
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Active, not recruiting
Active, not recruiting
Recruiting
Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL
Active, not recruiting
Active, not recruiting
KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
Recruiting
Active, not recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer3 recruiting
- Lung cancer3 recruiting
- Metastatic breast cancer3 recruiting
- Acute myeloid leukaemia2 recruiting
- Myeloproliferative neoplasms2 recruiting
- Bladder cancer1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Melanoma1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Recruiting
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Recruiting
Terminated
Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors
Recruiting
Completed
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
Completed
Terminated
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
Completed
A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
Completed
A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma
Terminated
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
Site data: ClinicalTrials.govUpdated 12 Nov 2026